Schatz et al derived a scale based on long-term use of beta-agonists by a patient with asthma. This can help identify a patient with poorly-controlled asthma who may benefit from more aggressive management. The authors are from Kaiser-Permanente Medical Care Program, University of Pennsylvania and Harvard School of Public Health.
